Quest Partners LLC 89bio, Inc. Transaction History
Quest Partners LLC
- $575 Billion
- Q1 2024
A detailed history of Quest Partners LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 2,487 shares of ETNB stock, worth $22,383. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,487
Previous 10,465
76.24%
Holding current value
$22,383
Previous $117 Million
75.23%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ETNB
# of Institutions
165Shares Held
89.2MCall Options Held
584KPut Options Held
1.17M-
Janus Henderson Group PLC London, X012.6MShares$113 Million0.08% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$66.4 Million1.38% of portfolio
-
Black Rock Inc. New York, NY6.64MShares$59.7 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.3MShares$56.7 Million3.14% of portfolio
-
State Street Corp Boston, MA5.54MShares$49.9 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $418M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...